GRASS PEPTIDES FOR VACCINE

(19)

(11)

EP 2 393 830 B8

(12)	CORRECTED EUROPEAN PATENT SPECIFICATION
	Note: Bibliography reflects the latest situation

(15)	Correction information:
	Corrected version no 1 (W1 B1)

(48)	Corrigendum issued on:
	18.03.2015 Bulletin 2015/12

(45)	Mention of the grant of the patent:
	28.01.2015 Bulletin 2015/05

(21)	Application number: 10704399.4

(22)	Date of filing: 05.02.2010

(51)

International Patent Classification (IPC):

C07K 14/415^(2006.01)
C07K 7/08^(2006.01)
A61K 38/16^(2006.01)
A61K 38/10^(2006.01)

C07K 7/06^(2006.01)
A61K 38/04^(2006.01)
A61K 39/36^(2006.01)

(86)	International application number:
	PCT/GB2010/000198

(87)	International publication number:
	WO 2010/089554 (12.08.2010 Gazette 2010/32)

(54)	GRASS PEPTIDES FOR VACCINE GRASPEPTIDE FÜR IMPFSTOFFE VACCIN À BASE DE PEPTIDES

(84)	Designated Contracting States:
	AT BE BG CH CY CZ DE DK EE ES FI FR GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR

(30)

Priority:

05.02.2009 GB 0901928
05.02.2009 GB 0901927
20.07.2009 GB 0912578
14.08.2009 WO PCT/GB2009/001995
12.10.2009 GB 0917871

(43)	Date of publication of application:
	14.12.2011 Bulletin 2011/50

(60)	Divisional application:
	15152164.8

(73)	Proprietor: Circassia Limited
	Oxford OX4 4GA (GB)

(72)	Inventors:
	HAFNER, Rod Oxford OX4 4GA (GB) LAIDLER, Paul Oxford OX4 4GA (GB) LAYTON, Guy Oxford OX4 4GA (GB) LARCHE, Mark Ontario L8N 3Z5 (CA)

(74)	Representative: Woods, Geoffrey Corlett
	J A Kemp 14 South Square Gray's Inn London WC1R 5JJ London WC1R 5JJ (GB)

(56)

References cited: :

WO-A1-03/024998
WO-A2-96/03106
WO-A2-2009/022154

WO-A1-2006/008018
WO-A2-2007/140505
WO-A2-2009/022157

JUTEL ET AL: "Allergen-specific immunotherapy with recombinant grass pollen allergens" JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, MOSBY, INC, US LNKD- DOI:10.1016/J.JACI.2005.06.004, vol. 116, no. 3, 1 September 2005 (2005-09-01), pages 608-613, XP005068191 ISSN: 0091-6749
SWOBODA INES ET AL: "Mutants of the major ryegrass pollen allergen, Lol p 5, with reduced IgE-binding capacity: candidates for grass pollen-specific immunotherapy." EUROPEAN JOURNAL OF IMMUNOLOGY JAN 2002 LNKD- PUBMED:11782018, vol. 32, no. 1, January 2002 (2002-01), pages 270-280, XP002581444 ISSN: 0014-2980

Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).